AI Assistant
Blog
Pricing
Log In
Sign Up
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.